| Literature DB >> 8527008 |
S P Molinari1, R Kaminski, A Di Rocco, M D Yahr.
Abstract
Seven patients with idiopathic Parkinson's disease were enrolled in a ten week study to evaluate the efficacy of famotidine, an histamine H2-antagonist, in the treatment of bradyphrenia. Patients received famotidine 80 mg/day for a period of six weeks and were evaluated with neuropsychological tests. Overall, patients demonstrated improvement in variables measured. Some patients also reported an improvement in their motor symptoms.Entities:
Mesh：
Substances：
Year: 1995 PMID： 8527008 DOI： 10.1007/bf02259665
Source DB: PubMed Journal: J Neural Transm Park Dis Dement Sect ISSN： 0936-3076